BioCorRx (BICX) Return on Capital Employed (2011 - 2026)

BioCorRx (BICX) has 16 years of Return on Capital Employed data on file, last reported at 79.96% in Q1 2026.

• Quarterly Return on Capital Employed rose 2827.0% year-over-year to 79.96% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 79.96% (up 2827.0% YoY) and the FY2025 annual result came in at 68.63%, up 313.0% from the prior year.
• Return on Capital Employed eased to 79.96% in Q1 2026 per BICX's latest filing, from 143.88% in the prior quarter.
• The five-year high for Return on Capital Employed was 147.38% in Q1 2022, with the low at 76.52% in Q3 2025.
• Average Return on Capital Employed over 5 years is 79.57%, with a median of 78.3% recorded in 2023.
• Year-over-year, Return on Capital Employed sank 85387 bps in 2022 and surged 7729 bps in 2025.
• BioCorRx's Return on Capital Employed stood at 102.78% in 2022, then plunged by 38 bps to 63.45% in 2023, then grew by 5 bps to 66.59% in 2024, then soared by 116 bps to 143.88% in 2025, then sank by 44 bps to 79.96% in 2026.
• Business Quant data shows BICX's Return on Capital Employed at 79.96% in Q1 2026, 143.88% in Q4 2025, and 76.52% in Q3 2025.